Searchable abstracts of presentations at key conferences in endocrinology

ea0051oc1.1 | Oral Communications 1 | BSPED2017

Dexamethasone for the treatment of 11-beta-hydroxysteroid-dehydrogenase Type 2 deficiency treatment in an adolescent

Prasad Pallavi , Mushtaq Talaq

11-beta-hydroxysteroid-dehydrogenase type 2 deficiency (11bHSD2) or syndrome of apparent mineralocorticoid excess is an autosomal recessive condition that characteristically presents with hypokalaemia and hypertension. In this condition, cortisol is not inactivated to cortisone and thus the excess cortisol cross reacts with the mineralocorticoid receptors in the kidney leading to hypertension, hypokalaemia and suppressed plasma renin activity (PRA) and aldosterone levels. The ...